title: Is BCG and "orphan" drug suffering from chemotherapists' overkill?
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D004345:Drug Industry; D005260:Female; D006801:Humans; D007167:Immunotherapy; D007938:Leukemia / Q000628:therapy*; D008223:Lymphoma / Q000628:therapy*; D008297:Male; D009163:Mycobacterium bovis / Q000276:immunology*; D009369:Neoplasms / Q000628:therapy*; D009965:Orphan Drug Production; D011897:Random Allocation